The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. (Q45916401)
Jump to navigation
Jump to search
scientific article published on 30 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. |
scientific article published on 30 July 2009 |
Statements
1 reference
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. (English)
1 reference
1 reference
1 reference
W D Fairlie
1 reference
K D Mason
1 reference
S L Khaw
1 reference
K C Rayeroux
1 reference
E Chew
1 reference
E F Lee
1 reference
A P Grigg
1 reference
J F Seymour
1 reference
D C S Huang
1 reference
30 July 2009
1 reference
1 reference
23
1 reference
11
1 reference
2034-2041
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference